Mili Kit
Product Images NDC 65862-776

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Mili (NDC 65862-776). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Norgestimate Fig1)

This is a product label for a contraceptive medication called "o" (norgestimate and ethinylestradiol tablets USP). The label includes information on the medication dosage (0.250 mg/0.35 mg) and instructions on which day of the week to take the medication (MON, TUE, WED, THU, FRI, SAT, SUN). The label also includes placeholders for additional labels, which can be peeled and placed on medication packaging.*

FDA Label Image

Figure 2 (Norgestimate Fig2)

FDA Label Image

Figure 3 (Norgestimate Fig3)

The text provided is a mixture of names of various women's health studies conducted between 2002 and 2017. There are mentions of contraception and hormone registers, as well as statistical data represented in numerical form. However, without additional context, it is difficult to provide a specific description of the subject matter.*

FDA Label Image

Blister Pack (Norgestimate Fig4)

This text appears to be a comparison of various birth control methods and their effectiveness in preventing pregnancy. It includes statistics on the average number of pregnancies per 100 women using different methods, such as implants, injections, intrauterine devices, sterilization, birth control pills, condoms, and more. It also suggests alternative methods such as avoiding sex during the most fertile days of the monthly cycle, using spermicide or the withdrawal method.*

FDA Label Image

Blister Pack (Norgestimate Fig5)

FDA Label Image

Package Label-principal Display Panel (0.250 mg/0.035 mg Carton Label)

This is a label for a pharmaceutical drug named "Norgestimate and Ethinyl Estradiol tablets USP" with a strength of "0.250 mg/0.035 mg". The label also contains some gibberish characters and repetitive mentions of "Dark Blue" and "Green".*

FDA Label Image

Norgestimate Fig7

This is a package insert for norgestimate and ethinyl estradiol tablets, USP, used for birth control. The recommended dosage is one tablet daily as prescribed. The package includes label stickers and should be kept out of the reach of children. The product is not meant to protect against HIV or other sexually transmitted infections. It is distributed by Aurobindo Pharma USA, Inc. Storage should be at 20° to 25°C (68° to 77°F). There are two options for starting the pills: Sunday start or Day 1 start. If this is the first time taking birth control pills, the patient should wait until the day their period starts to begin taking them.*

FDA Label Image

Chemical Structure (Norgestimate Str)

Ethinyl estradiol is a synthetic hormone used in combination with progestin as a component of hormonal contraceptives. It is also used to treat menopausal symptoms such as hot flashes and vaginal dryness.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.